Official statistics reveal stark regional disparities in global innovation. The World Intellectual Property Organization (WIPO) reports that in 2024, Asia accounted for 70.1% of worldwide patent applications, while Latin America and the Caribbean (LAC) combined held roughly 1.5%, a share that has declined over the past decade. Resident patent filings for the entire LAC region numbered around 8,385 in recent World Bank data, with individual nations like Brazil filing approximately 8,000 and Mexico around 2,000—figures dwarfed by small European countries despite a combined LAC population exceeding 600 million. Denmark, with just 6 million people, exemplifies concentrated impact through Novo Nordisk's development of Ozempic (semaglutide), a major 21st-century pharmaceutical breakthrough.

This output gap persists despite notable historical exceptions. Argentina has produced multiple scientific Nobel laureates, including Bernardo Houssay (Physiology/Medicine, 1947), Luis Leloir (Chemistry, 1970), and César Milstein (Physiology/Medicine, 1984), though several conducted pivotal work abroad. Such achievements remain limited relative to population and contrast with the near-absence of globally dominant 21st-century technologies or firms originating in the region.

Argentina's trajectory offers a deeper case study in long-term decline. Once among the world's wealthiest nations per capita in the early 20th century—benefiting from vast natural resources and heavy European immigration—its economy unraveled through repeated political instability after 1930, military coups, import-substitution policies that diverted investment from agriculture, chronic inflation, populist governance, and failure to build competitive industry. Sources document how these institutional failures, rather than resource scarcity, drove decades of crises, hyperinflation, debt defaults, and stagnation.

Mainstream analyses emphasize policy, corruption, inequality, and extractive institutions. Yet heterodox perspectives, drawing on patterns of civilizational output, national IQ correlations with innovation metrics, and human biodiversity research, suggest deeper factors: despite high European genetic ancestry in countries like Argentina and Uruguay, outcomes diverge sharply from peer European or East Asian populations. This raises questions of selection effects among immigrants, admixture dynamics, gene-culture coevolution, and whether cognitive and behavioral distributions constrain institutional quality over generations—patterns observed in broader global data that mainstream discourse often attributes solely to colonialism or economics. These lenses connect South American underperformance to wider civilizational trajectories, including potential Western decline if similar dysgenic or institutional patterns intensify. The data on patent filings and economic history provide quantifiable backing for disparities the original thread dramatizes, even if its 'zero inventions' framing overlooks real but scaled-limited contributions.